drugset / Trial / NCT01879618
Use Of Fragmin In Hemodialysis
NaSingle-groupOpen-labelTreatment
Summary
The study will determine if the Fragmin dose can be adjusted to suit the clinical needs of patients during dialysis.
Timeline
- Start
- 2013-10
- Primary completion
- 2016-03
- Completion
- 2016-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dalteparin sodium | Other / unclassified | 5000 iu | — |